Skip to content

Epimed 301-1815

by Epimed International, Inc

Epimed 301-1815 is a Class II device made by Epimed International, Inc, listed in FDA GUDID since 26 Aug 2020 (UDI-DI 00818788023483), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00818788023483 UDI-DI Date26 Aug 2020ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Epimed
Generic name
Percutaneous radio-frequency ablation probe, denervation, monopolar, single-use
Model / Ref / Catalog
301-1815
Primary DI / UDI-DI
00818788023483
FDA product code
GXI
GMDN term
Percutaneous radio-frequency ablation probe, denervation, monopolar, single-use
Device class
Class II
Regulation number
882.4725
GUDID distribution status
In Commercial Distribution
Sterilisation method
Ethylene Oxide
MRI safety
MR Unsafe
Size
Needle Gauge — 18 Gauge
Length — 15 Centimeter
Length — 10 Millimeter

Similar devices

Other devices filed under FDA product code GXI (Probe, radiofrequency lesion).

Other devices from Epimed International, Inc

See all devices from Epimed International, Inc →

Properties

  • Supplied sterile
  • Sterilise before use
  • Single use
  • Prescription use
  • Lot / batch number
  • Manufacturing date
Other properties (9, all answered No)